Kassberg Thomas Richard
Insider CIK 1303811 · RARE Chief Business Officer & SVP · PASG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PASG Passage BIO, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 10,539 | — | $0 | 10,539 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 143,789 | — | $0 | 143,789 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-03-03 | 2025-03-04 | 6,028 | $42.10 | $253.8K | 265,238 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2025-03-03 | 2025-03-04 | 508 | $42.92 | $21.8K | 264,730 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-03-01 | 2025-03-04 | 18,443 | — | $0 | 271,266 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2024-09-30 | 2024-10-02 | 174,139 | — | $0 | 174,139 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-03-11 | 2024-03-12 | 11,509 | $49.93 | $574.6K | 252,823 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2024-03-01 | 2024-03-05 | 31,400 | — | $0 | 31,400 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-03-01 | 2024-03-05 | 957 | — | $0 | 265,617 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2024-03-01 | 2024-03-05 | 274 | $53.69 | $14.7K | 265,343 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-03-01 | 2024-03-05 | 1,011 | $53.76 | $54.4K | 264,332 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-03-01 | 2024-03-05 | 17,800 | — | $0 | 264,660 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2023-10-23 | 2023-10-24 | 39,878 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2023-10-23 | 2023-10-24 | 39,878 | $6.86 | $273.6K | 286,738 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2023-10-23 | 2023-10-24 | 39,878 | $32.78 | $1.31M | 246,860 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2023-03-01 | 2023-03-03 | 39,400 | — | $0 | 39,400 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-03-01 | 2023-03-03 | 22,000 | — | $0 | 252,222 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2023-03-01 | 2023-03-03 | 1,968 | $45.27 | $89.1K | 250,254 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | D To issuer | 2023-03-01 | 2023-03-03 | 3,394 | $45.65 | $154.9K | 246,860 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-03-01 | 2023-03-03 | 2,663 | — | $0 | 230,222 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-03-11 | 2022-03-15 | 10,281 | $67.01 | $688.9K | 227,559 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2022-03-01 | 2022-03-03 | 24,900 | — | $0 | 24,900 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2022-03-01 | 2022-03-03 | 14,000 | — | $0 | 227,840 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-03-01 | 2022-03-03 | 2,374 | $66.62 | $158.2K | 213,840 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-10-14 | 2021-10-18 | 286 | $81.14 | $23.2K | 216,266 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2021-09-30 | 2021-10-01 | 109,734 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2021-09-30 | 2021-10-01 | 109,734 | $0.31 | $34.0K | 216,552 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-05-06 | 2021-05-10 | 363 | $113.69 | $41.3K | 106,818 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2021-03-01 | 2021-03-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 4,636 | — | $0 | 111,614 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-03-01 | 2021-03-03 | 4,572 | $138.17 | $631.7K | 107,181 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 5,500 | — | $0 | 106,978 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-10-14 | 2020-10-16 | 262 | $87.98 | $23.1K | 101,478 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-06-01 | 2020-06-03 | 348 | $69.38 | $24.1K | 101,740 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-05-06 | 2020-05-08 | 248 | $66.26 | $16.4K | 101,675 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-04-19 | 2020-04-21 | 248 | $58.57 | $14.5K | 101,923 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2020-03-01 | 2020-03-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-03-01 | 2020-03-03 | 2,067 | $56.08 | $115.9K | 102,171 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 5,634 | — | $0 | 104,109 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 6,800 | — | $0 | 98,475 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-10-14 | 2019-10-16 | 1,434 | — | $0 | 91,675 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-06-01 | 2019-06-04 | 346 | $54.93 | $19.0K | 90,241 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-05-21 | 2019-05-22 | 381 | $59.50 | $22.7K | 90,587 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-05-06 | 2019-05-07 | 1,434 | — | $0 | 90,968 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-04-19 | 2019-04-23 | 248 | $64.43 | $16.0K | 89,226 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2019-03-05 | 2019-04-17 | 832 | $65.52 | $54.5K | 89,474 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-03-01 | 2019-04-17 | 21,500 | — | $0 | 21,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-03-01 | 2019-04-17 | 7,000 | — | $0 | 90,306 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-03-01 | 2019-03-04 | 21,500 | — | $0 | 21,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-03-01 | 2019-03-04 | 806 | $67.55 | $54.4K | 89,499 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-03-01 | 2019-03-04 | 7,000 | — | $0 | 90,305 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-06-01 | 2018-06-04 | 346 | $73.73 | $25.5K | 83,114 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-05-21 | 2018-05-22 | 381 | $64.79 | $24.7K | 83,460 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-04-19 | 2018-04-19 | 1,431 | — | $0 | 83,529 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2018-03-01 | 2018-03-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-03-01 | 2018-03-05 | 307 | $48.43 | $14.9K | 82,098 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-03-01 | 2018-03-05 | 6,000 | — | $0 | 82,405 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2017-06-01 | 2017-06-01 | 376 | $56.61 | $21.3K | 76,228 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2017-05-21 | 2017-05-22 | 414 | $57.47 | $23.8K | 76,604 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2017-03-01 | 2017-03-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2017-03-01 | 2017-03-01 | 3,000 | — | $0 | 76,790 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2016-06-01 | 2016-06-03 | 24,000 | — | $0 | 24,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2016-06-01 | 2016-06-03 | 4,000 | — | $0 | 73,790 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2016-05-21 | 2016-05-24 | 414 | $64.01 | $26.5K | 69,790 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-08-12 | 2015-08-14 | 3,334 | $109.70 | $365.7K | 70,204 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-07-08 | 2015-07-10 | 3,334 | $102.12 | $340.5K | 73,538 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-06-10 | 2015-06-12 | 3,334 | $88.19 | $294.0K | 76,872 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2015-05-21 | 2015-05-27 | 26,300 | — | $0 | 26,300 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2015-05-21 | 2015-05-27 | 4,400 | — | $0 | 80,206 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-05-13 | 2015-05-15 | 3,334 | $72.04 | $240.2K | 75,806 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-04-08 | 2015-04-10 | 3,333 | $58.02 | $193.4K | 79,140 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-03-11 | 2015-03-13 | 3,333 | $56.30 | $187.6K | 82,473 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-02-11 | 2015-02-13 | 3,333 | $54.31 | $181.0K | 85,806 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2015-01-14 | 2015-01-16 | 3,333 | $51.51 | $171.7K | 89,139 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-12-10 | 2014-12-12 | 3,333 | $40.22 | $134.1K | 92,472 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-11-12 | 2014-11-14 | 3,333 | $41.85 | $139.5K | 95,805 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-10-08 | 2014-10-10 | 3,333 | $53.26 | $177.5K | 99,138 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-09-10 | 2014-09-12 | 3,333 | $54.82 | $182.7K | 102,471 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-09-03 | 2014-09-04 | 10,000 | $55.00 | $550.0K | 105,804 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2014-09-02 | 2014-09-04 | 10,000 | $52.82 | $528.2K | 115,804 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | C Conversion deriv | 2014-02-05 | 2014-02-11 | 98,595 | — | $0 | 0 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | C Conversion | 2014-02-05 | 2014-02-11 | 31,454 | — | $0 | 125,804 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | P Buy | 2014-01-30 | 2014-02-03 | 1,500 | $21.00 | $31.5K | 94,350 | SEC↗ |